Lonza Group Ag Current Ratio 2012-2024 | LZAGY
Current and historical current ratio for Lonza Group Ag (LZAGY) from 2012 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Lonza Group Ag current ratio for the three months ending December 31, 2024 was 0.00.
| Lonza Group Ag Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-12-31 | $6.18B | $4.07B | 1.52 |
| 2024-06-30 | $5.89B | $2.89B | 2.04 |
| 2023-12-31 | $5.46B | $3.08B | 1.77 |
| 2023-06-30 | $6.26B | $3.02B | 2.08 |
| 2022-12-31 | $5.99B | $3.23B | 1.86 |
| 2022-06-30 | $5.91B | $2.72B | 2.17 |
| 2021-12-31 | $6.52B | $2.59B | 2.51 |
| 2021-06-30 | $5.52B | $3.41B | 1.62 |
| 2020-12-31 | $5.12B | $3.30B | 1.55 |
| 2020-06-30 | $3.25B | $2.01B | 1.62 |
| 2019-12-31 | $3.06B | $2.69B | 1.14 |
| 2019-06-30 | $2.92B | $2.25B | 1.30 |
| 2018-12-31 | $3.60B | $2.43B | 1.48 |
| 2018-06-30 | $3.04B | $2.68B | 1.14 |
| 2017-12-31 | $2.78B | $2.21B | 1.26 |
| 2017-06-30 | $5.02B | $1.64B | 3.05 |
| 2016-12-31 | $2.10B | $1.66B | 1.27 |
| 2016-06-30 | $1.99B | $1.34B | 1.49 |
| 2015-12-31 | $1.92B | $1.64B | 1.17 |
| 2015-06-30 | $1.94B | $2.07B | 0.94 |
| 2014-12-31 | $2.05B | $1.70B | 1.21 |
| 2014-06-30 | $2.20B | $1.22B | 1.81 |
| 2013-12-31 | $1.96B | $1.25B | 1.57 |
| 2013-06-30 | $2.07B | $1.17B | 1.77 |
| 2012-12-31 | $2.10B | $1.39B | 1.51 |
| 2012-06-30 | $2.09B | $1.83B | 1.14 |
| 2011-12-31 | $2.14B | $1.08B | 1.99 |
| 2011-06-30 | $1.45B | $1.19B | 1.22 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $48.219B | $7.468B |
| Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.079B | 26.17 |
| EssilorLuxottica (ESLOY) | France | $171.331B | 0.00 |
| Boston Scientific (BSX) | United States | $152.232B | 34.81 |
| Stryker (SYK) | United States | $138.522B | 27.50 |
| Medtronic (MDT) | Ireland | $122.971B | 17.34 |
| Agilent Technologies (A) | United States | $41.624B | 26.94 |
| ResMed (RMD) | United States | $35.677B | 24.69 |
| GE HealthCare Technologies (GEHC) | United States | $33.321B | 15.94 |
| Koninklijke Philips (PHG) | Netherlands | $27.607B | 18.03 |
| Insulet (PODD) | United States | $23.404B | 72.64 |
| Terumo (TRUMY) | Japan | $22.638B | 25.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.819B | 11.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.952B | 0.00 |
| Baxter (BAX) | United States | $9.495B | 7.66 |
| Sunny Optical Technology (SNPTF) | China | $9.361B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.447B | 30.37 |
| Demant (WILYY) | Denmark | $7.346B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.515B | 10.71 |
| Haemonetics (HAE) | United States | $3.440B | 15.31 |
| ICU Medical (ICUI) | United States | $3.370B | 21.40 |
| Envista Holdings (NVST) | United States | $3.190B | 18.30 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.886B | 13.16 |
| LeMaitre Vascular (LMAT) | United States | $2.006B | 40.38 |
| Perrigo (PRGO) | Ireland | $1.896B | 4.75 |
| Phibro Animal Health (PAHC) | United States | $1.828B | 18.26 |
| AtriCure (ATRC) | United States | $1.636B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.450B | 9.32 |
| Neogen (NEOG) | United States | $1.389B | 26.62 |
| Curaleaf Holdings (CURLF) | Canada | $1.385B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.287B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.245B | 18.02 |
| Tilray Brands (TLRY) | Canada | $1.213B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.195B | 52.36 |
| BioLife Solutions (BLFS) | United States | $1.159B | 343.86 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.931B | 0.00 |
| InMode (INMD) | Israel | $0.896B | 10.12 |
| Valneva SE (VALN) | France | $0.778B | 0.00 |
| Surmodics (SRDX) | United States | $0.595B | 0.00 |
| Omeros (OMER) | United States | $0.558B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.495B | 17.03 |
| CeriBell (CBLL) | United States | $0.479B | 0.00 |
| Evolus (EOLS) | United States | $0.468B | 0.00 |
| SNDL (SNDL) | Canada | $0.441B | 0.00 |
| BillionToOne (BLLN) | $0.402B | 0.00 | |
| Cresco Labs (CRLBF) | United States | $0.344B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.340B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Cerus (CERS) | United States | $0.311B | 0.00 |
| Brainsway (BWAY) | Israel | $0.308B | 52.53 |
| Sanuwave Health (SNWV) | United States | $0.283B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.257B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.256B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.244B | 143.67 |
| Viemed Healthcare (VMD) | United States | $0.243B | 19.36 |
| High Tide (HITI) | Canada | $0.236B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.227B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Exagen (XGN) | United States | $0.204B | 0.00 |
| Organigram Global (OGI) | Canada | $0.204B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 15.64 |
| FitLife Brands (FTLF) | United States | $0.170B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.166B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.149B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.126B | 0.00 |
| Biote (BTMD) | United States | $0.115B | 5.04 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 13.25 |
| Sharps Technology (STSS) | United States | $0.087B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.049B | 20.77 |
| Nephros (NEPH) | United States | $0.047B | 33.85 |
| Cytosorbents (CTSO) | United States | $0.041B | 0.00 |
| Jin Medical (ZJYL) | China | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Modular Medical (MODD) | United States | $0.029B | 0.00 |
| Bonk (BNKK) | United States | $0.029B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.30 |
| Zynex (ZYXI) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.012B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Functional Brands (MEHA) | $0.003B | 0.00 | |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |